Rapid Micro Biosystems, Inc. reaffirmed revenue guidance for the fiscal year 2023. for the year, the company expects its total revenue guidance of at least $22.0 million, representing growth of approximately 30% compared to full year 2022, and the placement of at least 15 systems.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.78 USD | +0.65% |
|
+1.30% | +5.41% |
05-03 | Transcript : Rapid Micro Biosystems, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
05-03 | Earnings Flash (RPID) RAPID MICRO BIOSYSTEMS Posts Q1 Revenue $5.6M | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.41% | 33.43M | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- RPID Stock
- News Rapid Micro Biosystems, Inc.
- Rapid Micro Biosystems, Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023